RESUMEN
OBJECTIVE: YKL-40 is a chitin-binding glycoprotein, the level of which increases in inflammatory diseases, diabetes mellitus (DM), cardiovascular diseases, and tumors. Gingival crevicular fluid (GCF) contains many proteins and markers of periodontitis. The purpose of this study was to investigate YKL-40 level in GCF from patients with periodontitis and DM and the association between YKL-40 level and chronic periodontitis (CP) or DM. SUBJECTS AND METHODS: The subjects were 121 patients with DM, CP, DM and periodontitis (DM-P), and healthy subjects (H). GCF was collected using paper strips after the sites for GCF collection were clinically evaluated for probing depth (PD), gingival index (GI), and bleeding on probing (BOP). YKL-40 in GCF was identified by Western blotting, and its level was determined by ELISA. RESULTS: YKL-40 was contained in GCF samples from H, DM, CP, and DM-P sites, and its levels (amount and concentration) in CP and DM-P were significantly higher than those in H and DM. GCF YKL-40 level significantly correlated with PD and GI, and its level in BOP-positive sites was significantly higher than that in BOP-negative ones. CONCLUSIONS: GCF YKL-40 level was elevated in periodontitis, but not DM. YKL-40 in GCF may be an inflammatory marker for periodontitis.
Asunto(s)
Proteína 1 Similar a Quitinasa-3/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Líquido del Surco Gingival/metabolismo , Periodontitis/metabolismo , Anciano , Biomarcadores/sangre , Biomarcadores/metabolismo , Western Blotting/métodos , Estudios de Casos y Controles , Proteína 1 Similar a Quitinasa-3/sangre , Periodontitis Crónica/sangre , Periodontitis Crónica/metabolismo , Diabetes Mellitus Tipo 2/sangre , Ensayo de Inmunoadsorción Enzimática/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pérdida de la Inserción Periodontal/metabolismo , Índice Periodontal , Bolsa Periodontal/metabolismo , Periodontitis/sangre , Periodontitis/diagnósticoRESUMEN
Although glomerular hematuria is likely a sign of chronic kidney disease that will develop into overt nephropathy after donation, it remains unclear whether prospective donors with hematuria should be excluded. We reviewed the medical records of 242 donors who donated at our institution from 2001 to 2007 and surveyed the prevalence of hematuria pre- and postdonation. We then investigated the association of hematuria with proteinuria postdonation and trends in glomerular filtration rate. Before donation, 8.3% of 242 donors presented with persistent hematuria, a finding that was significantly associated with dysmorphic hematuria before donation. Most cases of predonation persistent hematuria persisted after donation, and the overall prevalence increased to 15.3%. During a median follow-up period of 2.3 years after donation, 8.3% developed persistent proteinuria, with incidence being significantly higher in donors having persistent hematuria with dysmorphic red blood cells (d-RBC) both before and after donation. Postdonation persistent hematuria with d-RBC was also associated with a progressive decline in renal function. These results indicate that persistent glomerular hematuria is strongly associated with a higher incidence of postdonation progressive kidney disease. Potential donors with persistent glomerular hematuria should be excluded, while those with isolated hematuria need to be evaluated with heightened caution.
Asunto(s)
Hematuria/complicaciones , Enfermedades Renales/etiología , Donadores Vivos , Nefrectomía/efectos adversos , Anciano , Progresión de la Enfermedad , Diuresis , Femenino , Estudios de Seguimiento , Tasa de Filtración Glomerular , Hematuria/diagnóstico , Hematuria/fisiopatología , Humanos , Enfermedades Renales/complicaciones , Enfermedades Renales/fisiopatología , Masculino , Persona de Mediana Edad , Selección de Paciente , Proteinuria/diagnóstico , Proteinuria/epidemiología , Proteinuria/etiología , Estudios Retrospectivos , Factores de RiesgoRESUMEN
AIM: Autoimmune pancreatitis (AIP) is a rare subtype of chronic pancreatitis. AIP has been suggested to be complicated by tubulointerstitial nephritis or glomerulonephritis, implying that the kidney is involved as a phenotype of IgG4-positive multi-organ lymphoproliferative syndrome; however, the clinical significance of this novel entity is not well-defined. METHODS: We conducted a retrospective cohort analysis of 47 (male, 39; female, 8) AIP patients. RESULTS: The patients (mean age, 70.3 +/- 9.5 years) had a mean observation period of 4.1 years. Before treatment, renal dysfunction with an eGFR of 30 and 15 ml/min/1.73 m2 developed only in 10.6% (5/47) and 2.1% (1/47) of the patients, respectively. Nevertheless, urinary N-acetyl-beta-D-glucosaminidase and alpha1-microglobulin levels were elevated in 78.6% (11/14) and 30.8% (4/13) of the patients, respectively. Renal involvement in contrast-enhanced CT imaging was present in 18.2% (8/44) of the patients and was associated with proteinuria (p = 0.04) and a decrease in eGFR (p < 0.01). Furthermore, a follow-up CT study (mean, 545 days) revealed improved kidney lesions in 80.0% (4/5) of the patients after oral corticosteroid administration. In contrast, first-time kidney involvements appeared newly in 3.6% (1/28) of the patients after steroid therapy for nonrenal AIP symptoms, and in 14.3% (1/7) of the patients under no specific therapy (p = 0.02). CONCLUSION: Although severe renal failure develops rarely in AIP patients, renal abnormalities have been significantly detected by biochemical and radiological tests. Oral corticosteroid administration, even when not targeting symptomatic nephropathy, can treat and prevent kidney involvements in AIP.
Asunto(s)
Enfermedades Autoinmunes/patología , Enfermedades Renales/patología , Riñón/patología , Pancreatitis Crónica/patología , Enfermedades Autoinmunes/complicaciones , Enfermedades Autoinmunes/diagnóstico por imagen , Enfermedades Autoinmunes/tratamiento farmacológico , Estudios de Cohortes , Femenino , Glucocorticoides/uso terapéutico , Humanos , Riñón/diagnóstico por imagen , Enfermedades Renales/complicaciones , Enfermedades Renales/diagnóstico por imagen , Enfermedades Renales/tratamiento farmacológico , Masculino , Pancreatitis Crónica/complicaciones , Pancreatitis Crónica/diagnóstico por imagen , Pancreatitis Crónica/tratamiento farmacológico , Prednisona/uso terapéutico , Radiografía , Análisis de Regresión , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
The clinical course and risk factors for developing end-stage renal disease (ESRD) after heminephrectomy in living kidney donors have scarcely been investigated. We reviewed medical records and identified eight case donors who developed chronic kidney disease (CKD) stage 5 or ESRD, and subsequently investigated the association between postoperative clinical courses and changes in renal function. To conduct a case-control study, we also selected a control group comprising 24 donors who had maintained stable renal function and were matched for age, sex and follow-up time since donation. Except for one donor who developed ESRD caused by a traffic accident, none of the donors developed progressive renal dysfunction immediately after donation. Their renal functions remained stable for a long period of time, but started to decline after developing new comorbidities, especially risk factors known as progression factors (proteinuria or hypertension) or accelerating factors (cardiovascular [CV] event or infection) of CKD. As compared with the control donors, incidence of postoperative persistent proteinuria, acute CV event, severe infection and hospitalization due to accelerating factors of CKD were significantly higher in the case donors. These results suggest the importance of long-term (more than 10 years) follow-up of donors with special attention on the risk factors of CKD.
Asunto(s)
Fallo Renal Crónico/epidemiología , Trasplante de Riñón , Donadores Vivos , Nefrectomía/efectos adversos , Anciano , Estudios de Casos y Controles , Nefropatías Diabéticas/epidemiología , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Hipertensión Renal/epidemiología , Riñón/fisiología , Masculino , Persona de Mediana Edad , Nefrectomía/estadística & datos numéricos , Proteinuria/epidemiología , Factores de RiesgoRESUMEN
BACKGROUND AND OBJECTIVE: Calprotectin, a heterodimer of S100A8 and S100A9 with antimicrobial properties, is expressed in gingival keratinocytes and plays an important role in innate immunity. Because calprotectin expression is localized in the spinous cell layer of the gingival epithelium, we hypothesized that the expression of calprotectin in keratinocytes is related to the differentiation stage. The aim of the present study was to investigate the relationship between calprotectin expression and keratinocyte differentiation using some factors that regulated its differentiation. MATERIAL AND METHODS: Normal human gingival keratinocytes were isolated from gingival tissues obtained at the extraction of wisdom teeth, and were cultured in serum-free keratinocyte medium supplemented with interleukin-1alpha or calcium, which promote keratinocyte differentiation, and transforming frowth factor-beta (TGF-beta) or retinoic acid, which suppress its differentiation. The expression of S100A8/A9 mRNA and the production of calprotectin in normal human gingival keratinocytes were examined by northern blotting and enzyme-linked immunosorbent assay, respectively. The expression of cytokeratin 14, involucrin and filaggrin (marker proteins of keratinocyte differentiation) was investigated by immunohistochemical staining, and the DNA-binding activity of CCAAT/enhancer binding protein alpha (C/EBPalpha), a transcription factor, was examined by electrophoretic mobility shift assay. RESULTS: The expression of S100A8/A9 mRNA and the production of calprotectin were increased by interleukin-1alpha and calcium, but decreased by TGF-beta. RA inhibited the expression of S100A8/A9 and keratinocyte differentiation, which were induced by interleukin-1alpha. C/EBPalpha DNA-binding activity in normal human gingival keratinocytes was enhanced by interleukin-1alpha and calcium, but suppressed by TGF-beta. CONCLUSION: The present study suggests that calprotectin expression is related to keratinocyte differentiation and that C/EBPalpha is a regulator of calprotectin expression in keratinocytes.
Asunto(s)
Encía/efectos de los fármacos , Interleucina-1alfa/farmacología , Queratinocitos/efectos de los fármacos , Complejo de Antígeno L1 de Leucocito/efectos de los fármacos , Factor de Crecimiento Transformador beta/farmacología , Proteína alfa Potenciadora de Unión a CCAAT/análisis , Calcio/farmacología , Calgranulina A/análisis , Calgranulina A/efectos de los fármacos , Calgranulina B/análisis , Calgranulina B/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Medio de Cultivo Libre de Suero , Proteínas Filagrina , Regulación de la Expresión Génica/efectos de los fármacos , Encía/citología , Humanos , Queratina-14/análisis , Queratinocitos/metabolismo , Complejo de Antígeno L1 de Leucocito/análisis , Fosfoproteínas/análisis , Precursores de Proteínas/análisis , Tretinoina/farmacologíaRESUMEN
Calprotectin, a major cytosolic protein of leukocytes, is detected in neutrophils, monocytes/macrophages, and epithelial cells. This protein is known to be a marker for several inflammatory diseases and is detected in inflammatory gingival tissue with periodontal disease. Recently, we found that the calprotectin level in gingival crevicular fluid from periodontitis patients was significantly higher than that of healthy subjects. However, the regulation of calprotectin in periodontal disease is unclear. In the present study, we investigated the effect of lipopolysaccharides of periodontopathic bacteria on calprotectin release from human neutrophils. Neutrophils from healthy donors were treated with lipopolysaccharides from Porphyromonas gingivalis (P-LPS), Actinobacillus actinomycetemcomitans, Prevotella intermedia, Fusobacterium nucleatum, and Escherichia coli. Calprotectin of neutrophil was identified by immunoblotting and calprotectin amount was determined by ELISA. Two subunits (10 and 14 kDa) of calprotectin were observed in the cell and medium fractions from neutrophils. P-LPS increased calprotectin release from seven to 16 times the control level after 30 min and its effect appeared in a dose-dependent manner (10-1000 ng/ml). Lipopolysaccharides from A. actinomycetemcomitans, P. intermedia, F. nucleatum, and E. coli also induced calprotectin release from neutrophils. These results suggest that lipopolysaccharides from periodontopathic bacteria induce calprotectin release from human neutrophils.
Asunto(s)
Complejo de Antígeno L1 de Leucocito/efectos de los fármacos , Lipopolisacáridos/farmacología , Neutrófilos/efectos de los fármacos , Porphyromonas gingivalis , Adulto , Aggregatibacter actinomycetemcomitans , Biomarcadores/análisis , Células Cultivadas , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática , Escherichia coli , Fusobacterium nucleatum , Líquido del Surco Gingival/química , Humanos , Immunoblotting , Complejo de Antígeno L1 de Leucocito/análisis , Neutrófilos/metabolismo , Periodontitis/metabolismo , Prevotella intermedia , Factores de TiempoRESUMEN
The urinary levels of 8-hydroxydeoxyguanosine (8-OH-dG), a marker of oxidative DNA damage, of 318 healthy men aged 18 - 58 were measured with high resolution by a newly developed automated high-pressure liquid chromatography (HPLC) system coupled to an electrochemical detector (ECD). The mean 8-OH-dG level (mg / g creatinine) was 4.12 +/- 1.73 (SD). An eleven-fold inter-individual variation was observed. The accuracy of the measurement estimated from the recovery of an added 8-OH-dG standard was 90 - 98%. By univariate analysis, it was found that moderate physical exercise (P = 0.0023) and high body mass index (BMI) (P = 0.0032) reduced the 8-OH-dG level, while physical labor (P = 0.0097), smoking (P = 0.032), and low meat intake (less than once / week) (P = 0.041) increased its level. Based on a multi-regression analysis of the log-transformed values, moderate physical exercise (P = 0.0039), high BMI (P = 0.0099), and age (P = 0.021) showed significant reducing effects on the 8-OH-dG level, while low meat intake (P = 0.010), smoking (P = 0.013), and day-night shift work (P = 0.044) increased its level. These results suggest that many types of life-style factors that either generate or scavenge oxygen radicals may affect the level of oxidative DNA damage of each individual.
Asunto(s)
Daño del ADN , Desoxiguanosina/análogos & derivados , Desoxiguanosina/orina , Estilo de Vida , 8-Hidroxi-2'-Desoxicoguanosina , Adolescente , Adulto , Análisis de Varianza , Biomarcadores/orina , Índice de Masa Corporal , Cromatografía Líquida de Alta Presión/métodos , Ejercicio Físico , Humanos , Masculino , Carne , Persona de Mediana Edad , Oxidación-Reducción , Fumar/orina , Tolerancia al Trabajo ProgramadoRESUMEN
We measured the levels of 8-hydroxyguanine (8-OH-Gua) and its repair activity in the livers of the Donryu rat, the carcinogen-resistant DRH rat, and the ddy mouse, which were fed a 0.06% 3'-methyl-4-dimethylaminoazobenzene (3'-MeDAB)-containing diet. In a short-term rat experiment (maximum 2 months), 3'-MeDAB did not increase the 8-OH-Gua levels in the livers of the two rat strains, although it significantly increased the repair activity in only the Donryu rat liver at 1 and 2 months. After long-term 3'-MeDAB administration to the ddy mouse (8 months), the levels of 8-OH-Gua and its repair activity were increased in the liver by 3.6-fold and 1.6-fold, respectively. These experiments suggest that 3'-MeDAB increases 8-OH-Gua generation in rodent liver DNA and the 8-OH-Gua repair assay is a reliable marker of cellular oxidative stress induced by carcinogens.
Asunto(s)
Carcinógenos/toxicidad , Colorantes/toxicidad , Daño del ADN/fisiología , Reparación del ADN/fisiología , Guanina/análogos & derivados , Hígado/metabolismo , Metildimetilaminoazobenceno/toxicidad , Estrés Oxidativo/fisiología , Animales , ADN/efectos de los fármacos , ADN/metabolismo , ADN-Formamidopirimidina Glicosilasa , Susceptibilidad a Enfermedades , Guanina/metabolismo , Hígado/efectos de los fármacos , Neoplasias Hepáticas Experimentales/inducido químicamente , Neoplasias Hepáticas Experimentales/genética , Neoplasias Hepáticas Experimentales/metabolismo , Masculino , Ratones , N-Glicosil Hidrolasas/biosíntesis , N-Glicosil Hidrolasas/genética , ARN Mensajero/biosíntesis , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de TiempoRESUMEN
BACKGROUND: Calprotectin, a major cytosol protein of leukocytes, exists in plasma and other body fluids of healthy human subjects. Since the calprotectin concentration rises markedly in some inflammatory diseases including rheumatoid arthritis, this protein has been thought to be a marker of inflammatory disease. Recently, we identified calprotectin in human dental calculus and gingival crevicular fluid (GCF), and found that the calprotectin concentration in GCF from patients with periodontitis was significantly higher than that in GCF from healthy subjects. In the present study, the association of GCF calprotectin level with GCF volume, gingival index (GI), and levels of biochemical markers including collagenase and aspartate aminotransferase (AST) in GCF was investigated to clarify the relationship between GCF calprotectin level and periodontal inflammation. METHODS: Ninety GCF samples collected from periodontal pockets with a probing depth of more than 4 mm in 54 patients with adult periodontitis were used for these assays. The GCF volume was measured, and GI in each site was recorded. The calprotectin content in GCF samples was determined by ELISA using a specific antibody. The activity of collagenase or AST was measured by a respective assay kit. RESULTS: The total amount of calprotectin and GCF volume showed a highly significant correlation (r = 0.64, P <0.0001), whereas the calprotectin concentration had no correlation with the GCF volume (r = 0.01, P= 0.924). The mean calprotectin concentration in GCF increased with the degree of GI, and the concentration in individual samples was significantly correlated with the GI score (r = 0.56, P<0.0001). Significant positive correlations were observed in GCF calprotectin versus collagenase (r = 0.57, P <0.0001) and GCF calprotectin versus AST levels (r = 0.40, P <0.005). CONCLUSIONS: From the present results and our previous findings, it is shown that the GCF calprotectin level significantly correlates not only with clinical indicators but also with current biochemical marker levels and that calprotectin may be a useful marker for periodontal inflammation.
Asunto(s)
Antígenos de Superficie/análisis , Aspartato Aminotransferasas/análisis , Proteínas de Unión al Calcio/análisis , Colagenasas/análisis , Líquido del Surco Gingival/química , Glicoproteínas de Membrana/análisis , Moléculas de Adhesión de Célula Nerviosa/análisis , Índice Periodontal , Periodontitis/metabolismo , Adulto , Anciano , Biomarcadores/análisis , Ensayo de Inmunoadsorción Enzimática , Femenino , Líquido del Surco Gingival/enzimología , Humanos , Complejo de Antígeno L1 de Leucocito , Masculino , Persona de Mediana Edad , Bolsa Periodontal/enzimología , Bolsa Periodontal/metabolismo , Periodontitis/enzimología , Estadística como AsuntoRESUMEN
Clinical and biochemical markers of periodontal disease have been used for precise objective diagnosis of periodontal inflammation. Interleukin 1beta (IL-1beta) and prostaglandin E2 (PGE2), inflammatory factors, levels in gingival crevicular fluid (GCF) of patients with periodontal disease are elevated and have been studied as biochemical markers. The levels of calprotectin, a leukocyte protein, in body fluids of patients with some inflammatory diseases are raised. Recently, we detected calprotectin in GCF and its concentrations in periodontal pockets were higher than those in healthy gingival crevices. In this study, we investigated the correlations between GCF calprotectin levels and clinical indicators (probing depth and bleeding on probing, BOP), and the IL-1beta or PGE2 levels in GCE Probing depth and BOP at 130 sites of 110 subjects with periodontal or other oral diseases were examined, then GCF samples were collected and their calprotectin, IL-1beta and PGE2 were determined by ELISA. The calprotectin level correlated positively with the probing depth and was significantly higher at BOP-positive than BOP-negative sites. There were significant, positive correlations between the calprotectin and IL-1beta or PGE2 concentrations. These results indicate that the calprotectin level in GCF correlates well with clinical and biochemical markers of periodontal disease and suggest that calprotectin may be useful for evaluating the extent of periodontal inflammation.
Asunto(s)
Proteínas de Unión al Calcio/análisis , Líquido del Surco Gingival/química , Glicoproteínas de Membrana/análisis , Moléculas de Adhesión de Célula Nerviosa/análisis , Enfermedades Periodontales/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Periodontitis Agresiva/metabolismo , Biomarcadores/análisis , Dinoprostona/análisis , Ensayo de Inmunoadsorción Enzimática , Femenino , Hemorragia Gingival/metabolismo , Humanos , Interleucina-1/análisis , Complejo de Antígeno L1 de Leucocito , Masculino , Persona de Mediana Edad , Enfermedades Periodontales/diagnóstico , Bolsa Periodontal/metabolismo , Periodontitis/metabolismo , Periodoncio/metabolismoAsunto(s)
Líquido del Surco Gingival/química , Glicoproteínas de Membrana/análisis , Moléculas de Adhesión de Célula Nerviosa/análisis , Periodontitis/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Complejo de Antígeno L1 de Leucocito , Masculino , Persona de Mediana Edad , Estadísticas no ParamétricasRESUMEN
Antioxidant activities of caffeoyltryptophan were investigated by the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging system, the superoxide anion generation system and the superoxide anion-mediated linoleic acid peroxidation system. At 10 microM, caffeoyltryptophan showed greater scavenging activity on DPPH than dl-alpha-tocopherol or ascorbic acid. DPPH radical scavenging activity of caffeoyltryptophan increased dose-dependently at concentrations ranging from 1 to 50 microM; 1 mol of caffeoyltryptophan reacted with ca 4 mol of radical. Caffeoyltryptophan caused 80% inhibition of superoxide anion generation at 50 microM. The inhibitory activity of caffeoyltryptophan was as strong as that of 5-caffeoylquinic acid. Caffeoyltryptophan inhibited the formation of conjugated diene from linoleic acid. The inhibitory activity increased in the order caffeic acid < 5-caffeoylquinic acid < caffeoyltryptophan < dl-alpha-tocopherol. Effects on the in vitro haemolysis and peroxidation of mouse erythrocytes induced by H2O2 were also examined. Caffeoyltryptophan exhibited strong inhibitory activities; Tryptophan was ineffective in these systems. These data suggest that caffeoyltryptophan may be a natural antioxidant in the human diet and, as such, may intervene in toxicological processes that are mediated by radical mechanisms.
Asunto(s)
Antioxidantes/farmacología , Ácidos Cafeicos/farmacología , Hemólisis/efectos de los fármacos , Ácido Linoleico/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Triptófano/análogos & derivados , Animales , Antioxidantes/química , Ácidos Cafeicos/química , Depuradores de Radicales Libres/química , Depuradores de Radicales Libres/farmacología , Masculino , Ratones , Triptófano/química , Triptófano/farmacologíaRESUMEN
Kynureninase [E.C.3.7.1.3.] is one of the enzymes involved in the biosynthesis of NAD cofactors from tryptophan through the kynurenine pathway. By tryptic and CNBr digestion of purified rat liver kynureninase, we obtained about 28% of the amino acid sequence of the enzyme. The rat kynureninase cDNA, isolated by means of reverse-transcribed polymerase chain reaction and hybridization screening, codes for a polypeptide of 464 amino acids. Northern blot analysis revealed the synthesis of a 2.0 kb rat kynureninase mRNA. A cDNA encoding human liver kynureninase was also isolated. The deduced amino acid sequence is 85% identical to that of the rat protein. COS-1 cells were transfected with both cDNAs. The Km values of the rat enzyme, for L-kynurenine and DL-3-hydroxykynurenine, were 440 +/- 20 microM and 32 +/- 5 microM and of the human enzyme 440 /- 20 microM and 49 +/- 6 microM, respectively. Interestingly, COS-1 cells transfected with the cDNA coding for rat kynureninase also display cysteine-conjugate beta-lyase activity.
Asunto(s)
Liasas de Carbono-Azufre , Hidrolasas/genética , Hígado/enzimología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Northern Blotting , Células COS , Clonación Molecular , Expresión Génica/genética , Humanos , Hidrolasas/química , Hidrolasas/metabolismo , Cinética , Quinurenina/análogos & derivados , Quinurenina/metabolismo , Liasas/metabolismo , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , ARN Mensajero/análisis , ARN Mensajero/genética , Ratas , Alineación de Secuencia , Análisis de Secuencia , Transfección/genéticaRESUMEN
In the mammalian brain, kynurenine aminotransferase (KAT) is pivotal to the synthesis of kynurenic acid, a preferential antagonist at the strychnine-insensitive NMDA-glycine site. As NMDA receptors are involved in autonomic function, we have examined the immunohistochemical localization of KAT in the medulla and spinal cord of the rat. KAT immunoreactivity (KAT-li) was found throughout these areas, in both glia and neurons. Unlike the mainly astrocytic localization in forebrain structures, KAT-li was predominantly neuronal, notably in areas important for blood pressure and heart rate regulation: ventral medulla, nucleus ambiguus, nucleus of the solitary tract and intramediolateral cell column of the spinal cord. The presence of KAT in these nuclei supports a neuromodulatory role for kynurenic acid in NMDA-mediated autonomic function.
Asunto(s)
Liasas , Bulbo Raquídeo/enzimología , Médula Espinal/enzimología , Transaminasas/análisis , Animales , Astrocitos/citología , Astrocitos/enzimología , Masculino , Bulbo Raquídeo/citología , Neuroglía/citología , Neuroglía/enzimología , Neuronas/citología , Neuronas/enzimología , Especificidad de Órganos , Lóbulo Parietal/citología , Lóbulo Parietal/enzimología , Prosencéfalo/citología , Prosencéfalo/enzimología , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Núcleo Solitario/enzimología , Médula Espinal/citologíaAsunto(s)
Saccharomyces cerevisiae/enzimología , Triptófano Oxigenasa/metabolismo , Triptófano/farmacología , Animales , Cromatografía por Intercambio Iónico , Electroforesis en Gel Bidimensional , Electroforesis en Gel de Poliacrilamida , Inducción Enzimática , Inhibidores Enzimáticos/farmacología , Hemo/metabolismo , Hígado/enzimología , Mamíferos , Peso Molecular , Pseudomonas/enzimología , Saccharomyces cerevisiae/efectos de los fármacos , Especificidad por Sustrato , Triptófano Oxigenasa/biosíntesis , Triptófano Oxigenasa/aislamiento & purificaciónRESUMEN
The physiological activating mechanism for human placental indoleamine 2,3-dioxygenase was investigated. No cell fractions of the placental homogenate were found to replace the electron-mediation activity of methylene blue from a reductant to the enzyme in the exogenous enzyme-activating system with L-ascorbic acid, B-NADPH, or B-NADH as a reductant. However, the preincubation at 37 degrees C of the supernatant fraction (10,000 x g, 30 min) prior to starting the indoleamine 2,3-dioxygenase reaction drastically caused the activation of the enzyme without added reductants and methylene blue, which suggests the existence of an endogenous indoleamine 2,3-dioxygenase-activating system. The endogenous enzyme activation was induced in the placentas delivered operatively by vacuum extraction or cesarean section much more significant degree than in those delivered normally.
Asunto(s)
Cesárea , Placenta/enzimología , Triptófano Oxigenasa/metabolismo , Extracción Obstétrica por Aspiración , Adulto , Ácido Ascórbico/farmacología , Activación Enzimática/efectos de los fármacos , Femenino , Humanos , NAD/farmacología , NADP/farmacología , Placenta/efectos de los fármacos , Embarazo , Triptófano Oxigenasa/efectos de los fármacosRESUMEN
Alanine-glyoxylate aminotransferase (AGT) 2 is a pyridoxal 5'-phosphate dependent, mitochondrial enzyme which, in the rat, is expressed at a high level in the kidney. The amino acid sequences of nine tryptic and seven CNBr peptides of the rat kidney AGT2 were determined. Three overlapping cDNAs encoding the AGT2 were cloned on the basis of its partial amino acid sequences by means of a polymerase chain reaction-based approach involving rat kidney poly(A)+ RNA. The complete cDNA sequence comprised 1,919 bases, and contained a 1,536-base open reading frame which encodes a polypeptide of 512 amino acid residues with a putative presequence consisting of 39 amino acid residues at the amino terminus, giving a precursor protein with a molecular mass of 57,150 Da. The sequence of AGT2 exhibits significant homology with neither peroxisomal AGT1 from human liver nor mitochondrial AGT1 from rat liver. However, the sequence of AGT2 exhibited 30.8, 29.2, and 27.1% identity with those of Escherichia coli 4-aminobutyrate aminotransferase, rat ornithine aminotransferase, and Pseudomonas cepacia 2,2-dialkylglycine decarboxylase, respectively. The active site sequences were also well conserved among these aminotransferases. AGT2, thus, is more similar to the other aminotransferases than to AGT1. The results suggest that the rat kidney AGT2 may play a biological role in amino acid metabolism distinct from that of AGT1.
Asunto(s)
Alanina Transaminasa/genética , ADN Complementario/genética , Isoenzimas/genética , Riñón/metabolismo , Transaminasas , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Northern Blotting , Clonación Molecular , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , ARN/análisis , Ratas , Ratas Wistar , Homología de Secuencia de AminoácidoRESUMEN
Fed rats were exercised until exhaustion by almost 65% VO2max on a treadmill. In 2.5 min after the exercise, blood was collected from various vessels of the splanchnic bed. Metabolites, glucose, lactate, ketone body, and nitrogencompounds in the plasma, were measured. Glucose excretion from the liver was increased by exercise, but was not significant. The absorption by the kidney decreased to 30% by exercise. Lactate was highly absorbed by the kidney, lower limbs, and digestive tract by exercise. Exercise caused a 200-300% increase of the plasma beta-hydroxybutyrate, but the absorption by the kidney and the lower limbs was decreased. These data suggest that glucose is a good carbon source for the recovery, and that lactate is more useful than glucose, but ketone body is less effective at a very early recovery phase under fed condition. Amino acid balances in each organ except digestive tract were positive showing anabolic conditions of these organs even after exhaustive exercise at fed condition. Most amino acid concentrations in the plasma tended to decrease to 60-90% by exercise. Amino acids were excreted from the digestive tract, and were eventually absorbed by the liver in both rested and exercised rat. The digestive tract, therefore, seems to be a primary amino acids pool to supply them to the liver during the inter meal. Urea excretion from the liver was more than the absorbed ammonia showing that active deamination from amino acids was carrying on. The resulted carbon skeletons of the amino acids might be used for the gluconeogenesis in the liver.
Asunto(s)
Aminoácidos/sangre , Glucemia/metabolismo , Cuerpos Cetónicos/sangre , Circulación Esplácnica/fisiología , Amoníaco/metabolismo , Animales , Arterias/metabolismo , Lactatos/sangre , Ácido Láctico , Masculino , Esfuerzo Físico , Ratas , Ratas Wistar , Urea/metabolismo , Venas/metabolismoRESUMEN
The tryptophan pyrrole-ring cleavage enzyme (TPCE) was detected in the yeast Saccharomyces cerevisiae. TPCE activity existed constitutively and was markedly induced by culturing the cells in a medium containing 0.1% (w/v) L-tryptophan. We purified partially the enzyme from the L-tryptophan-induced cells by phospho-cellulose column chromatography. The partially purified enzyme was stimulated solely by L-ascorbic acid, a nonspecific reductant, suggesting that the yeast TPCE is not indoleamine 2,3-dioxygenase, but rather tryptophan 2,3-dioxygenase. The enzyme metabolized L-tryptophan preferentially, and D-tryptophan slightly. KCN and NaN3, exogenous ligands of heme, inhibited the enzyme activity drastically, indicating that yeast tryptophan 2,3-dioxygenase contains heme(s) in its active site. The optimal pH of the enzyme was 6.5. Upon two-dimensional polyacrylamide gel electrophoresis, a protein staining spot was identified that was induced by L-tryptophan and whose intensity changed in correlation with the tryptophan 2,3-dioxygenase activity after phospho-cellulose column chromatography. This protein, exhibiting a molecular weight of approximately 38,000 and an isoelectric point of approximately pH 8.0, may be identified as a subunit of yeast tryptophan 2,3-dioxygenase.
Asunto(s)
Proteínas Fúngicas/análisis , Saccharomyces cerevisiae/enzimología , Triptófano Oxigenasa/análisis , Azidas/farmacología , Sitios de Unión , Cromatografía Liquida , Electroforesis en Gel Bidimensional , Proteínas Fúngicas/antagonistas & inhibidores , Proteínas Fúngicas/aislamiento & purificación , Hemo/análisis , Concentración de Iones de Hidrógeno , Punto Isoeléctrico , Quinurenina/metabolismo , Cianuro de Potasio/farmacología , Azida Sódica , Especificidad por Sustrato , Triptófano/metabolismo , Triptófano Oxigenasa/antagonistas & inhibidores , Triptófano Oxigenasa/aislamiento & purificaciónRESUMEN
Male Wistar rats were injected by dimethoate (10 mg/0.5 ml) daily for 8 successive days. Controls received the same amount of saline., A group of 5 rats were anesthetized at 0, 2, 4, 6 and 8 days of injection. Blood was withdrawn from heart. serum lipid components and 4 species of serum esterases were assayed for each group. A general decrease in the activities of serum esterases was observed. A marked decrease also was observed in lipids profile during the 8 days course of experiment.